PubMed HealthSearch

Biomedical subjects

M A Camacho

Publications and source records attributed to M A Camacho.

8 recordsLinked to original sources

Experimental dermatophyte infection abated by povidone-iodine: assessment by computerized-assisted corneofungimetry.

The effect of antiseptics upon fungal growth inside human stratum corneum is poorly documented. Therefore the present study was undertaken to assess the anti-dermatophyte activity of a diluted povidone-iodine wash solution using the corneofungimetry bioassay. When compared to a non-medicated cleansing product, regular applications of the antimicrobial for two weeks significantly abated the fungal invasiveness inside human stratum corneum. The present findings are most likely relevant for the clinical practice.

Antifungal Agents

High performance liquid chromatographic method for the determination of lobenzarit disodium in a sustained release tablet formulation.

A rapid and simple high performance liquid chromatographic method is described and validated for the determination of lobenzarit disodium (CAS 64808-48-6) in a sustained release tablet formulation. The calibration graph was linear over the range 20-105 micrograms/ml. The sensitivity (discriminator capacity) was 2.079 micrograms/ml. The coefficient of variations for repeatability and reproducibility were less than 1.60% and 1.30%, respectively. The accuracy of the method did not depend on lobenzarit concentration in tablets. The mean recovery was found to be 100.62%. The method was selective, even when degradation products were present.

Antirheumatic Agents

Electrophysiological evidence for the nomenclature of the pudendal nerve and sacral plexus in the male rat.

Surgical microscopy and electrophysiological techniques were used to standardize the nomenclature for the pudendal nerve and sacral plexus according to their somatic axonal composition in the male rat. We conclude that the pudendal nerve is the segment running from the L6-S1 trunk to the sacral plexus, carrying efferent fibers to the coccygeus, internal obturator, ventral and dorsal bulbospongiosus, ischiocavernosus, external anal sphincter, and external urethral sphincter muscles, and afferent fibers from the penis, prepuce, scrotum, and ventral-proximal tail. The sacral plexus is the complex formed by the bridge-like structure connecting the pudendal nerve with the lumbosacral trunk, and two nerve branches emerging from it, one innervating the proximal half of the scrotal skin, and the other innervating the muscles at the base of the penis known as the motor branch. These branches are only considered as a part of the sacral plexus because they integrate axons from both the lumbosacral trunk and pudendal nerve. The gross anatomy of the pudendal nerve and sacral plexus has a main organization that was observed in 70% of cases, whereas the remaining 30% occurred in two variants. This nomenclature is appropriate to describe the pudendal nerve and sacral plexus in studies that involve them being lesioned or electrophysiologically analysed. A main additional finding was that two large afferent branches innervate the scrotum, one the proximal half and the other the distal half. As mentioned above, the proximal branch belongs to the sacral plexus, whereas the distal branch belongs to the pudendal nerve because all its axons travel to the cord via this nerve. Since stimulation or even manipulation of the scrotal branches resulted in the secretion of semen containing spermatozoa, it is suggested that scrotal afferents are involved in some way in the ejaculatory process, a topic that deserves further research.

Animals

MRI segmentation: methods and applications.

The current literature on MRI segmentation methods is reviewed. Particular emphasis is placed on the relative merits of single image versus multispectral segmentation, and supervised versus unsupervised segmentation methods. Image pre-processing and registration are discussed, as well as methods of validation. The application of MRI segmentation for tumor volume measurements during the course of therapy is presented here as an example, illustrating problems associated with inter- and intra-observer variations inherent to supervised methods.

Head

A three-dimensional finite element model of human transthoracic defibrillation: paddle placement and size.

A detailed 3-D finite element model of the conductive anatomy of the human thorax has been constructed to quantitatively assess the current density distribution produced in the heart and thorax during transthoracic defibrillation. The model is based on a series of cross-sectional CT scans and incorporates isotropic conductivities for eight tissues and an approximation of the anisotropic conductivity of skeletal muscle. Current density distributions were determined and compared for four paddle pairs and two paddle sizes. Our results show that the myocardial current density distributions resulting from a defibrillation shock were fairly uniform for the paddle pairs and sizes examined in this study. Specific details of the spatial distribution of the current density magnitudes in the heart were found to depend on paddle placement and size. When the minimum current necessary to defibrillate was delivered, the maximum myocardial current density produced with any of the paddle sizes and positions examined was less than four times the minimum current density necessary to render a myocyte in a fibrillating heart inexcitable, and less than 40% of the damage threshold. These results suggest that common clinically used defibrillation paddle positions have a safety margin as large as 2.5 for current and approximately 6 for energy.

Adult

Qualitative and quantitative determination of two new antitumor agents from 1-8 naphthalimides in tablets. Validation of a high performance liquid chromatography method.

A high performance liquid chromatography (HPLC) method for the qualitative and quantitative determination of amonafide (CAS 69408-81-7) and mitonafide (CAS 54824-17-8), two new antineoplastic molecules, in finished pharmaceutical dosage forms (tablets) is developed and validated. The results submitted in this work suggest that HPLC method is linear (range 0.54 microgram to 2.70 micrograms for amonafide, and 1.40 micrograms to 5.25 micrograms for mitonafide), sensitive (discriminator capacity 0.1098 microgram for amonafide and 0.1324 microgram for mitonafide), precise (coefficient of variation < or = 2.39% within run, < or = 1.18% between run for tablets with amonafide, and < or = 1.38% within run and < or = 0.96% between run for tablets with mitonafide), accurate (mean recovery 97.55, 98.85, 98.905% for the three different kinds of tablets with amonafide, and 100.73, 101.54% for the two types of tablets with mitonafide) and selective, even when degradation products are present. The volume of extractor liquid must be specially taken into account with regard to the accuracy of the method, because drug extraction can be influenced by the nature of the excipients.

Adenine

Photolability evaluation of the new cytostatic drug mitonafide.

A qualitative and quantitative study on the stability of the new cytostatic drug mitonafide (N-[2-(dimethyl-amino) ethyl]-3-nitronaphthalimide, CAS 54824-17-8) against UVA, UVC and visible radiations was carried out. Initially a test with controlled lighting on samples from mitonafide solution is carried out. This test include the determination of the protector effect of different kinds of glasses (clear and amber glass). The results achieved are verified by means of a test in normal lighting conditions (direct sun light, normal laboratory lighting and darkness). High mitonafide photodecomposition, deeper against UVA radiation, requires conservation of raw material in darkness. Similarly UV sterilizing radiations must be avoided in sterile rooms during manufacture. The use of amber glass ampoules is not enough to protect parenteral solutions from radiations. Direct sunlight must be avoided in the manufacture, control tests and administration in perfusion of pharmaceutical dosage forms, although artificial light can be used during short periods of time.

Antineoplastic Agents

High pressure liquid chromatographic determination of the new non-steroidal anti-inflammatory agent butibufen.

High performance liquid chromatography (HPLC) method for the determination and validation of a new non-steroidal anti-inflammatory agent, butibufen (CAS 55837-18-8), microencapsulated butibufen and its pharmaceutical forms--tablets, sachets (microencapsulated butibufen with excipients), microemulsion and cream--is described. Acetonitrile proved to be the best solvent for the extraction of butibufen from its pharmaceutical forms. The results submitted in this paper suggest that the HPLC method for the quantitative determination of butibufen is linear, accurate, precise and sensitive.

Anti-Inflammatory Agents, Non-Steroidal